Universal Corporation Q4 2026 Earnings Recap

Universal's shares inched up 1.4% post-earnings, reflecting a report that balanced modest revenue growth against significant noncash impairment charges and inventory write-downs, which constrained profitability and tempered investor enthusiasm.

Key Takeaways

• Fourth quarter consolidated revenue rose 2% year-over-year to $715 million; full year revenue was $2.9 billion, slightly lower than the prior year.
• Operating loss of $15 million in Q4 versus $43 million operating income a year ago; full year operating income declined $64 million to $169 million, largely due to a $41 million goodwill impairment at Shank’s Ingredients segment and inventory write-downs in dark air-cured tobacco.
• Net loss attributable to Universal was $43 million in Q4, compared to net income of $9 million last year; full year net income dropped to $33 million from $95 million.
• Tobacco segment revenue increased 3% in Q4 to $632 million but segment operating income declined from $46 million to $27 million, pressured by $43 million in inventory write-downs versus a $19 million charge last year.
• Ingredients segment revenue declined to $83 million in Q4 with operating income halving to $2 million; full year segment operating income fell sharply to $3 million from $12 million, weighed down by weaker Shank’s performance.